Analyst Conference Summaries

Biotechnology Investor Aids

Tetraphase Pharmaceuticals
TTPH

press release date: November 8, 2018 @ 1:30 PM Pacific Time

Biotech Bargain Basement: Tetraphase [January 2, 2019 at Seeking Alpha]

Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech [May 23, 2018 at Seeking Alpha]

Tetraphase Pharmaceuticals Trial Failure May Mask Value [February 27, 2018 at Seeking Alpha]

2018
 
May 3, 2018
August 2, 2018
Nov. 8, 2018
 

Tetraphase Pharmaceuticals (TTPH) is a clinical-stage biotechnology company specializing in multidrug-resistant antibiotic therapies.

Tetraphase Pharmaceutical web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 INTC
 ISRG
 MCHP
 MYL.
 PLX
 REGN
 SGEN
 VBLT
 VSTM
 XLNX
 XLRN
 
 

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2017 William P. Meyers